Acellular pertussis vaccines in Japan: past, present and future.
about
Acellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenThe epidemiology of pertussis in Germany: past and present.Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications.Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1-18 years.The Bordetella type III secretion system: its application to vaccine development.Bordetella pertussis strain variation and evolution postvaccination.The first steps towards the era of personalised vaccinology: predicting adverse reactions.Seroprevalence studies of pertussis: what have we learned from different immunized populations.Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis.Whither pertussis?Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study.
P2860
Q24193554-DEBDB995-26A0-481B-8A04-DE80B2BCA52CQ24201103-3E608B2D-6CAA-43F4-AE62-BAF81006AF8CQ24234899-4E52C180-CE44-44A4-872E-CC6744372149Q24243261-1C13A332-EC74-4E20-A412-D9F976605B22Q33412583-2900E62F-D792-4A8C-8917-0F3C6DCD731AQ33521111-94B22E80-4548-4E75-8FB2-B2B4AA105ED4Q33526658-E8ACFB25-A894-4849-8280-484AA35BCF08Q34091515-9CCEEB95-68BC-4E61-9D1E-1F33B3D4C4F1Q34666089-445A5F4C-E927-4AA8-B3EC-8B934263BC39Q36039305-580A8E4B-1C64-4E2B-B46C-037957DAB73AQ36436918-224EBC86-FE77-479C-9EED-B4289DC76CDBQ37124958-AA98D9B8-D60A-49E3-B715-D331D7BC56C7Q37524032-CC662633-CEA2-4E37-AA16-AE45C883DF08Q38257150-6259C839-7C62-4729-98E7-39AC95386CFDQ38553680-38E53725-16E6-4D3E-8F1F-B36D83B89779Q40115767-DFC744B1-A0E7-422F-BE80-03BF5AE89129Q41588991-3B6D439A-8738-4846-B539-91319BA5C0CEQ45204641-9FC502BD-DD2D-4BB2-91A2-6FC4ABAEA2FCQ47139846-29E4CD66-EB4C-4501-8650-D860FCD91318Q51691086-5A75979F-87D2-42A3-BE8B-3D3AB32AC525Q54208973-0A59BA40-03E0-49C1-95BB-004FADB984DBQ55470408-96985433-C5AF-4920-9A2B-A949D44EF9C4
P2860
Acellular pertussis vaccines in Japan: past, present and future.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Acellular pertussis vaccines in Japan: past, present and future.
@ast
Acellular pertussis vaccines in Japan: past, present and future.
@en
type
label
Acellular pertussis vaccines in Japan: past, present and future.
@ast
Acellular pertussis vaccines in Japan: past, present and future.
@en
prefLabel
Acellular pertussis vaccines in Japan: past, present and future.
@ast
Acellular pertussis vaccines in Japan: past, present and future.
@en
P2860
P356
P1476
Acellular pertussis vaccines in Japan: past, present and future.
@en
P2093
Masaaki Nagai
Mineo Watanabe
P2860
P304
P356
10.1586/14760584.4.2.173
P577
2005-04-01T00:00:00Z